Pharmaceutical formulations comprising amoxocyllin and clavulanate
CA 2280857 A1 · Owner: Smithkline Beecham S.A. · Inventors: Mention, Jacky Andre Gustave; Sanroma Bordallo, Jose Luis; Storm, Kevin
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Novel co-amoxiclav formulations are described having reduced weight compared , to existing formulations as well as formulations comprising amoxycillin and potassium clavulanate in a ratio of 8:1 and formulations prepared from granulates of amoxycillin and granulates of amoxycillin and clavulanate.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 10, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 10, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 10, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.